| HCVCX | JFLJX | HCVCX / JFLJX | |
| Total Expense Ratio | 1.80 | 0.43 | 419% |
| Annual Report Gross Expense Ratio | 1.80 | 0.43 | 419% |
| Fund Existence | 22 years | 9 years | - |
| Gain YTD | 0.927 | 1.013 | 91% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 15000000 | 0% |
| Min. Initial Investment IRA | 2000 | N/A | - |
| Net Assets | 143M | 4.43B | 3% |
| Annual Yield % from dividends | 2.39 | 3.67 | 65% |
| Returns for 1 year | 9.74 | 9.09 | 107% |
| Returns for 3 years | 24.36 | 22.97 | 106% |
| Returns for 5 years | 11.32 | 13.25 | 85% |
| Returns for 10 years | 52.97 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AIORX | 12.51 | 0.18 | +1.46% |
| American Century International Opps R | |||
| FVALX | 6.16 | 0.06 | +0.98% |
| Forester Value N | |||
| GIDUX | 9.01 | 0.01 | +0.11% |
| Goldman Sachs Intl Eq Div & Prem R6 | |||
| GIEZX | 16.49 | N/A | N/A |
| GuideStone Funds International Eq Inv | |||
| JAGLX | 81.26 | -0.51 | -0.62% |
| Janus Henderson Global Life Sciences T | |||